Boston Scientific (BSX) PT Raised to $67 at UBS
Tweet
Share
E-mailGet Alerts BSX Hot Sheet
Price: $52.01 +3.05%
Rating Summary:
33 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
33 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
UBS analyst Danielle Antalffy raised the price target on Boston Scientific (NYSE: BSX) to $67.00 (from $66.00) while maintaining a Buy rating.
You May Also Be Interested In
- Piper Sandler: PFA survey is most positive for Medtronic, Inc. (MDT)
- Royal Bank of Canada (RY:CN) (RY) PT Raised to Cdn$311 at CIBC
- CIBC Upgrades National Bank of Canada (NA:CN) (NTIOF) to Outperformer
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
